LARP4 Antibody [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-22253C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen this antibody was made to, maps to a region between residue 450 and 500 of human La Ribonucleoprotein Domain Family, Member 4 using the numbering given in entry NP_443111.4 (GeneID 113251).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for LARP4 Antibody [DyLight 650]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LARP4
Alternate Names
c-Mpl binding protein, DKFZp686E039, La ribonucleoprotein domain family member 4, La ribonucleoprotein domain family, member 4, la-related protein 4, MGC74631, PP13296
Gene Symbol
LARP4
Additional LARP4 Products
Product Documents for LARP4 Antibody [DyLight 650]
Product Specific Notices for LARP4 Antibody [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...